Downstream Bioprocessing 2021

Vectors

Downstream Bioprocessing 2021

Downstream Bioprocessing 2021

Filter by ContentType

Stepping foot into a successful partnership to support your viral vector therapy through commercialization

Stepping foot into a successful partnership to support your viral vector therapy through commercialization

Minh Hong, Marc Gaal
12 January 2022
Interview
 Enrichment of full rAAV capsids in a scalable, reproducible viral vector manufacturing platform

Enrichment of full rAAV capsids in a scalable, reproducible viral vector manufacturing platform

A Hejmowski, M Olson, A MacIntyre et al
13 December 2021
Innovator Insight
 The route to downstream process and analytical innovation for efficient AAV vector manufacture

The route to downstream process and analytical innovation for efficient AAV vector manufacture

06 December 2021
Interview
 Current trends in AAV downstream bioprocessing and future considerations

Current trends in AAV downstream bioprocessing and future considerations

Michael Mercaldi
06 December 2021
Interview
 COVID-19 vaccine approvals: key lessons for mRNA therapeutics

COVID-19 vaccine approvals: key lessons for mRNA therapeutics

V Indurthi, PhD, J Barberio, S Zobbi et al
06 December 2021
Poster
 Titration for research grade rAAV: understanding challenges and minimum requirements

Titration for research grade rAAV: understanding challenges and minimum requirements

Javier F Alcudia
06 December 2021
Viewpoint
 Development of a scalable adeno-associated virus purification process for gene therapy

Development of a scalable adeno-associated virus purification process for gene therapy

Åsa Hagner McWhirter
25 November 2021
FastFacts

Other editions


<< Back to Vectors channel